ConductScience.org, home

Paper38519366

Emerging roles of TBK1 in cancer immunobiology.

Miranda A and 2 others. Trends Cancer, 2024. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Emerging roles of TBK1 in cancer immunobiology. Papers, record 38519366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38519366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Emerging roles of TBK1 in cancer immunobiology.
PubMed
Journal
Trends Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
2.7, provisional
iCite
Revised in PubMed
2025-08-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miranda AAlex
2Shirley CACarl A
3Jenkins RWRussell W

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Protein Serine-Threonine KinasesMajor topic
Tumor MicroenvironmentMajor topic
Immunity, InnateMajor topic
Humans
Animals
Tumor Escape
Signal Transduction
Autophagy

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R37 CA283560NCI NIH HHSUnited StatesR37CA283560PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124449872Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24449872PubMed
230146158TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging.Cell2018https://conductscience.org/library/papers/30146158PubMed
329319049Mechanisms of resistance to immune checkpoint inhibitors.Br J Cancer2018https://conductscience.org/library/papers/29319049PubMed
432968282Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.Nature2020https://conductscience.org/library/papers/32968282PubMed
535074921Myeloid cell TBK1 restricts inflammatory responses.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/35074921PubMed
630842653Structural basis of STING binding with and phosphorylation by TBK1.Nature2019https://conductscience.org/library/papers/30842653PubMed
728187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
829301958A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Science2018https://conductscience.org/library/papers/29301958PubMed
924062311Loss of TBK1 induces epithelial-mesenchymal transition in the breast cancer cells by ERα downregulation.Cancer Res2013https://conductscience.org/library/papers/24062311PubMed
1025858804Immune checkpoint blockade: a common denominator approach to cancer therapy.Cancer Cell2015https://conductscience.org/library/papers/25858804PubMed
1131792381TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis.Nat Cell Biol2019https://conductscience.org/library/papers/31792381PubMed
1210581243NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.EMBO J1999https://conductscience.org/library/papers/10581243PubMed
1328356390The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity.J Exp Med2017https://conductscience.org/library/papers/28356390PubMed
1436634707Targeting TBK1 to overcome resistance to cancer immunotherapy.Nature2023https://conductscience.org/library/papers/36634707PubMed
1530290124Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza.Am J Respir Cell Mol Biol2019https://conductscience.org/library/papers/30290124PubMed
1622619329Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22619329PubMed
1730482939TBK1 and IKKε restrain cell death.Nat Cell Biol2018https://conductscience.org/library/papers/30482939PubMed
1834518217TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34518217PubMed
1932962465Targeting TANK-binding kinase 1 (TBK1) in cancer.Expert Opin Ther Targets2020https://conductscience.org/library/papers/32962465PubMed
2030778252Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.Nat Immunol2019https://conductscience.org/library/papers/30778252PubMed

See all 77 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42979158Closing the adaptive window: immune-metabolic strategies to constrain melanoma therapy resistance.Front Immunol2026https://conductscience.org/library/papers/42979158PubMed
42851781Minding the gates: dual cell-autonomous and non-cell-autonomous mechanisms of TBK1 in ALS/FTD.Front Neurosci2026https://conductscience.org/library/papers/42851781PubMed
42794728Expanding Synthetic Lethality in DNA Damage Response-Defective Cancers Through Stress Phenotype-Guided Kinase Targeting.Int J Mol Sci2026https://conductscience.org/library/papers/42794728PubMed
42768102Convergent TBK1 loss of function drives gasdermin E dependent pyroptosis and motor neuron degeneration across ALS genotypes.Cell Death Differ2026https://conductscience.org/library/papers/42768102PubMed
42719252Tumor microenvironment and signaling pathways in melanoma brain metastasis.Ann Transl Med2026https://conductscience.org/library/papers/42719252PubMed
42426285A micropeptide encoded by the lncRNA USP30-AS1 promotes tumor growth by attenuating cGAS-STING-type I IFN signaling in macrophages.Nat Cancer2026https://conductscience.org/library/papers/42426285PubMed
41950925Selective degradation of TBK1 uncovers mechanistic insights into blocking ccRCC progression.Cell Chem Biol2026https://conductscience.org/library/papers/41950925PubMed
41879499Natural Products as Autophagy-related Protein Kinase Inhibitors: A Future Promising Anticancer from Nature.Mini Rev Med Chem2026https://conductscience.org/library/papers/41879499PubMed
41376337CD47 blockade enhances cisplatin sensitivity by inhibiting DNA repair gene expression.Acta Biochim Biophys Sin (Shanghai)2025https://conductscience.org/library/papers/41376337PubMed
41315176Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing.Cell Death Discov2025https://conductscience.org/library/papers/41315176PubMed
40966363Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis.Cancer Res2026https://conductscience.org/library/papers/40966363PubMed
40833415Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40833415PubMed
40808675Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma.Front Pharmacol2025https://conductscience.org/library/papers/40808675PubMed
40484646Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer.J Immunother Cancer2025https://conductscience.org/library/papers/40484646PubMed
40076567TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases.Int J Mol Sci2025https://conductscience.org/library/papers/40076567PubMed
39871363Role of nasal microbiota in regulating host anti-influenza immunity in dogs.Microbiome2025https://conductscience.org/library/papers/39871363PubMed
39279883Mechanism of TBK1 activation in cancer cells.Cell Insight2024https://conductscience.org/library/papers/39279883PubMed
39086134Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer.Mol Ther2024https://conductscience.org/library/papers/39086134PubMed
38607079ZO-1 Regulates Hippo-Independent YAP Activity and Cell Proliferation via a GEF-H1- and TBK1-Regulated Signalling Network.Cells2024https://conductscience.org/library/papers/38607079PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SIK1150094PubTator's text mininghttps://conductscience.org/library/genes/150094NCBI Gene
TBK129110PubTator's text mininghttps://conductscience.org/library/genes/29110NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38519366

GET https://conductscience.org/api/papers/v1/38519366/references?page=2